$AVIR Cashflow Statement | Understand Stock

$AVIR

$4.17 +$0.01 (0.24%) Close

Financial Statements

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities
Stock-based compensation expense
Depreciation and amortization expense
Accretion of premium and discounts on marketable securities
Income tax benefit
Changes in operating assets and liabilities:
Prepaid expenses and other current assets
Other assets
Accounts payable
Accrued expenses and other liabilities
Deferred revenue
Operating lease liabilities

Net cash used in operating activities
Cash flows from investing activities
Additions to property and equipment
Purchases of marketable securities
Sales and maturities of marketable securities
Net cash provided by investing activities

Cash flows from financing activities
Proceeds from issuance of common stock
Proceeds from issuance of common stock under ESPP
Proceeds from issuance of common stock upon option exercise
Stock repurchase
Cash paid for taxes in connection with RSU and PSU vesting
Net cash (used in) provided by financing activities

Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at the beginning of period
Total cash and cash equivalents
Cash and cash equivalents
Restricted cash
Supplemental disclosure of non-cash financing activities:
Right of use assets obtained in exchange for operating lease liabilities

Comments